Medical Device Adhesive Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Medical Device Adhesive Market Trends and Insights

Surge in Remote-Monitoring and Wearable Therapeutic Devices

Wearable devices now demand skin adhesion for 7-14 days without sensitization. Medtronic showed silicone-acrylate hybrids cut erythema scores 35% versus standard acrylics in 2025 trials, thanks to silicone surface energies near 20 dynes/cm that limit protein adsorption^{[1]Medtronic, “Extended-Wear Infusion Set Clinical Results,” medtronic.com}. The FDA cleared 14 new adhesive-backed insulin-delivery systems during 2025, each passing ISO 10993-10 and -23 protocols. Co-development of tapes at the design stage has replaced retrofit approaches, optimizing peel strengths of 400-600 g/inch and moisture-vapor transmission above 800 g/m²/24 h.

Expansion of Single-Use and Minimally-Invasive Catheter Platforms

EU MDR 2017/745 tightened re-use rules in 2024, prompting rapid growth of disposable catheters. Boston Scientific reported 28% sales growth in single-use ureteroscopes aided by UV-curable balloon bonds with 5-second cure times^{[2]Boston Scientific, “Investor Presentation 2025,” bostonscientific.com}. Stryker applies low-viscosity cyanoacrylates that wick into less than100-µm gaps on neurovascular devices, meeting ISO 10993-18 extractables thresholds under 0.1 ppm. The quick cure slashes work-in-process inventories by 40%.

Growth in Home-Infusion Pumps Requiring Long-Wear PSAs

CMS broadened reimbursement in January 2025, lifting ambulatory pump placements 22% in H1. Baxter’s Novum IQ uses a hydrocolloid-bordered patch absorbing 3 g exudate per 10 cm², preventing tack loss of up to 40% over 4 days. ISO 15621 adaptation for wound-contact absorbency is now an informal payer prerequisite.

Wider Adoption of Hydrogel and Bio-Resorbable Adhesive Chemistries

Catechol-functionalized PEG adhesives lost 80% mass in 14 days yet delivered 150 kPa lap-shear on porcine skin, according to an Advanced Healthcare Materials 2025 study. Johnson & Johnson disclosed a thermosensitive hydrogel that gels at 32°C, enabling cold-chain storage and body-heat activation. FDA draft guidance (March 2025) recommends full ISO 10993 testing plus chronic-toxicity data for bio-resorbables exceeding 30-day wear.

Complex ISO-10993 Biocompatibility and Extractables Testing Burden

ISO 10993-1:2018 now mandates chemical characterization before biological tests, adding 18-24 months and USD 200,000-500,000 per new formulation. Contract-lab backlogs stretched to 16 weeks in 2025, delaying launches. REACH Annex XVII phthalate bans, effective June 2024, forced re-qualification of legacy tapes throughout Europe.

Cost Volatility of Medical-Grade Silicone and Specialty Acrylates

Silicone raw-material prices climbed 18-22% between Q1 2024 and Q2 2025 after supply disruptions at key Asian siloxane plants, squeezing margins by roughly 280 basis points at Wacker Chemie. Parallel 15-20% swings in 2-ethylhexyl acrylate spot pricing destabilized fixed-price OEM contracts, pushing smaller buyers toward water-based emulsions that carry 25-30% lower feedstock costs but give up 10-15% peel strength on silicone-coated liners.

Segment Analysis

By Resin: Silicone Chemistries Lead Sterilization-Tolerant Growth

Acrylics held 29.05% of the medical device adhesive market share in 2025 because of their USD 4.50-6.00/kg cost and 200-m/min coating speeds. Silicone resins are on track for an 8.11% CAGR between 2026 and 2031 as device makers favor adhesives that maintain greater than or equal to 400 g/in peel after 25-kGy gamma cycles. Yet ISO 10993-5 cytotoxicity scores below 1 for silicones are steering long-wear CGM and insulin-pump platforms their way. Niche cyanoacrylates, as seen in Ethicon’s Dermabond Prineo 2.0, cut closure time 30% in a 450-patient trial. 

Polyurethane chemistries underpin structural bonds in implantable pulse generators that require greater than or equal to 2,500 psi lap-shear, while epoxies dominate catheter-tip assembly. FDA clearance of six cyanoacrylate surgical sealants during 2025 confirms regulatory comfort when formaldehyde release stays under 2 ppm.

By Technology: UV-Curing Systems Outpace Solvent and Water Alternatives

Water-based chemistries retained 34.82% share of the medical device adhesive market size in 2025 under tight EU VOC caps, yet their 15-30 minute dry times limit throughput. Dymax’s 405-nm LED line cures to 75 Shore D in 3s, trimming energy use 85% versus mercury lamps. UV/radiation-curable adhesives will post an 8.35% CAGR through 2031, propelled by zero-VOC processing and sub-5-second cures that align with injection-molding tact times.

Solvent-based systems endure where gap filling or long open times are needed, and hot-melts are growing in surgical-drape attachment with 120-140°C melt points. Hybrid dual-cure epoxies that photopolymerize surfaces and dark-cure hidden joints over 24 h eliminate voids in complex geometries.

By Adhesive Form: Hydrocolloid Patches Gain in Home-Based Wound Care

Pressure-sensitive films and tapes led with 37.02% of 2025 revenue, yet gels and hydrocolloid patches are expected to grow at an 8.27% CAGR during the forecast period (2026-2031) as diabetic ulcer care shifts homeward. Smith & Nephew’s Allevyn Life absorbed 40% more exudate and cut dressing changes 18% year-on-year. Hydrocolloids swell 150-200%, distributing shear and keeping bacterial barriers intact for up to 7 days. 

Structural liquids, epoxies, urethanes, cyanoacrylates, anchor catheter components with tensile strengths more than 3,000 psi at service temperatures to 150°C. Sprayable cyanoacrylates with 10s tack-free times are entering surgical skin prep, while polyurethane foams expand 300-400% for negative-pressure therapy cavities.

By Application: Internal Uses Grow Fastest on Minimally Invasive Surgery

Medical devices and equipment represented 43.92% of 2025 sales, yet internal medical uses, surgical sealants, balloon bonds, and implantable assemblies will grow at an 8.54% CAGR through 2031. Baxter’s Tisseel reformulation shortened liver-resection hemostasis by 35%, saving 12 OR minutes per case. Regulatory pathways for fibrin and cyanoacrylate sealants now demand viral inactivation log-reductions greater than or equal to 6. 

External applications, wound dressings, transdermals, wearables, lean on silicone-acrylate hybrids that strip at less than 100 g/inch yet survive 5-day wear, while universal dental systems remove separate etch and prime steps, cutting restoration chair time by 5 minutes.

Geography Analysis

North America held 38.11% of global revenue in 2025, sustained by FDA 510(k) clearances that can close in 120 days and a critical mass of CGM and insulin-pump production. Abbott, Dexcom, and Medtronic shipped 8.2 million sensors in 2025, all using silicone-acrylate hybrids qualified to ISO 10993-10 for 14-day wear. Solventum’s spin-off unlocked USD 180 million for new ISO-10993 labs, while Henkel added 8,000 tons of UV-curable capacity in Mexico to meet near-shoring demand.

Asia-Pacific is the fastest-growing region at an 8.46% CAGR from 2026 to 2031. China’s NMPA aligned with ISO 10993 and saw a 12% device-market jump in 2025; Mindray and United Imaging integrated structural adhesives in new imaging gear. Japan okayed 18 adhesive-containing devices during 2025, and Dow opened a 3,500-ton silicone plant in Pune under India’s PLI scheme. South Korea’s MFDS approval of Samsung’s Galaxy Watch 6 Medical Edition showcased conductive polyurethane adhesives delivering 0.8 Ω/square sheet resistance during 20% wrist flex.

In Europe, MDR enforcement tightened evidence demands. Germany’s Lohmann converted 68% of its catalog to bio-based acrylates, lowering CO₂ footprints 22%. The U.K. introduced a fast-track path for FDA-cleared adhesives, France prioritized diabetic wound-care reimbursement, and Urgo’s hydrocolloid–silver dressing cut healing times 25%. Russia’s import-substitution policy spurred domestic cyanoacrylate launches at a 30-35% price edge.